
Dr. Stella Lee explores the past, present and future implementation of guidelines into daily practice

Dr. Palomares discusses how type 2 inflammation, an aberrant immune response, underlies skin diseases like atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria, linking to their clinical symptoms.

In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier describes a typical patient presentation in the pediatric asthma clinic and explores whether clinical remission is a goal of treatment for this patient and others like them.

In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier revisits a patient case study where a biologic has been added to an asthma management plan and describes the potential for this patient to achieve on-therapy clinical remission.
Join Professor Joaquim Mullol for a discussion of the emerging concept of clinical remission in CRSwNP.

Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP

Dr. Oscar Palomares explains that IL-4 and IL-13 are crucial cytokines in type 2 inflammation, playing both unique and overlapping roles, including T cell expansion and contributing to clinical symptoms in chronic diseases.

This video clip from the EAACI 2024 symposium highlights that a multidisciplinary approach is essential for the treatment of asthma.

Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.

Prof. Mullol share his opinion on connection between loss of smell and sleep disorder in patients with CRSwNP.

Explore resources on the importance of partnering with patients to empower them to take an active role in their care.

This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.